BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 157 filers reported holding BEAM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.50 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,746,920 | -25.8% | 72,637 | -1.4% | 0.00% | 0.0% |
Q2 2023 | $2,353,145 | +5.0% | 73,697 | +0.7% | 0.00% | 0.0% |
Q1 2023 | $2,240,527 | -22.9% | 73,172 | -1.6% | 0.00% | -40.0% |
Q4 2022 | $2,907,789 | -16.9% | 74,349 | +1.2% | 0.01% | -16.7% |
Q3 2022 | $3,500,000 | +22.8% | 73,468 | -0.2% | 0.01% | +20.0% |
Q2 2022 | $2,850,000 | -2.6% | 73,633 | +44.2% | 0.01% | +25.0% |
Q1 2022 | $2,926,000 | -34.4% | 51,068 | -8.7% | 0.00% | -20.0% |
Q4 2021 | $4,459,000 | -2.5% | 55,949 | +6.5% | 0.01% | -16.7% |
Q3 2021 | $4,572,000 | -45.1% | 52,546 | -18.8% | 0.01% | -40.0% |
Q2 2021 | $8,334,000 | +73.0% | 64,751 | +7.6% | 0.01% | +66.7% |
Q1 2021 | $4,816,000 | -2.3% | 60,165 | -0.3% | 0.01% | -14.3% |
Q4 2020 | $4,927,000 | +274.1% | 60,347 | +12.8% | 0.01% | +250.0% |
Q3 2020 | $1,317,000 | +151.8% | 53,480 | +186.5% | 0.00% | +100.0% |
Q2 2020 | $523,000 | +55.7% | 18,669 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $336,000 | – | 18,669 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |